Risperidone versus behaviour therapy in the treatment of tic disorders - a randomized single-blinded trial - Risperidone versus behaviour therapy for tics

HagaZiekenhuis0 个研究点目标入组 80 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Patients have to meet DSM-IV criteria for GTS or CTD, and will be included according to the Diagnostic Confidence Index. Both children and adults are included, ranging from 6 to 65 years of age. Written informed consent is necessary to participate in the study by the patient. In case the patient is under age of 16 a written consent of parents is necessary before a patient is included in the study.

•Exclusion criteria are: severe major depression, psychosis, addiction, mental deficiency, known cardiovascular disease, family history of QT prolongation, bradycardia, other medication known to prolong QT interval, and inability to read/ speak Dutch. Exclusion criteria will be established
•using the Mini International Neuropsychiatric Interview for adults, or the KIDDIE-SADS for children.Patients need to be free of antipsychotic medication for at least four weeks prior to entering the study.

发起方